Table 2 Comparison of endoscopic procedures in patients with or without known COVID-19 status
From: Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on
rtPCR result available | rtPCR result not available | Historic cohort 2019 | |
|---|---|---|---|
Patients (n) | 313 (89%) | 39 (11%) | 368 (100%) |
Gender (m/f) | 179 (57%)/134 (43%) | 26 (67%)/13 (33%) | 227 (62%)/141 (38%) |
Age | 62 ± 18 (1–95) | 64 ± 15 (30–91) | 63 ± 16 (3–88) |
In-patient / out-patient | 231 (74%)/82 (26%) | 25 (64%)/14 (36%) | 262 (71%)/106 (29%) |
Timing of endoscopy | |||
< 6 h of symptom onset | 26 (8%) | 14 (36%) | 29 (8%) |
6–24 h of symptom onset | 42 (13%) | 3 (8%) | 37 (10%) |
Routine | 245 (78%) | 22 (56%) | 302 (82%) |
Endoscopic procedure | |||
EGD | 161 (51%) | 23 (59%) | 191 (52%) |
Colonoscopy | 106 (34%) | 12 (31%) | 134 (36%) |
ERCP | 38 (12%) | 4 (10%) | 30 (8%) |
EUS | 8 (3%) | 0 (0%) | 13 (4%) |
Outcome emergency procedure | N = 68 | N = 16 | N = 66 |
Clinically significant finding | 56 (82%) | 12 (75%) | 43 (65%) |
Endoscopic haemostasis | 22 (32%) | 7 (44%) | 21 (32%) |
Biliary/pancreatic intervention | 13 (19%) | 3 (19%) | 4 (6%) |
Other endoscopic therapy | 3 (4%) | 1 (6%) | 8 (12%) |
Outcome routine procedures | N = 245 | N = 23 | N = 302 |
Clinically significant finding | 60 (25%) | 4 (17%) | 78 (26%) |
Endoscopic haemostasis | 3 (1%) | 0 (0%) | 1 (0.5%) |
Biliary/pancreatic intervention | 28 (11%) | 1 (4%) | 20 (8%) |
PEG/feeding tube | 8 (3%) | 2 (9%) | 5 (2%) |
Polypectomy | 18 (7%) | 2 (9%) | 43 (14%) |
Other endoscopic therapy | 7 (3%) | 0 (0%) | 9 (3%) |